ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)

PRESS RELEASE

published on 06/03/2026 at 20:19, 1 month 7 days ago

OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025

Résultats Financiers Trésorerie Document D’enregistrement Universel OSE Immunotherapeutics Audités
PRESS RELEASE

published on 06/03/2026 at 20:19, 1 month 7 days ago

OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
OSE Immunotherapeutics reports full year 2025 audited consolidated financial results and filing of 2025 Universal Registration Document, confirming cash runway with IRIS Financing

Universal Registration Document OSE Immunotherapeutics Cash Runway 2025 Financial Results IRIS Financing
BRIEF

published on 05/28/2026 at 21:09, 1 month 13 days ago

OSE Immunotherapeutics obtient un financement relais flexible en fonds propres

Plan Stratégique Investisseurs Institutionnels Développement Clinique Émission D'actions Financement Flexible
BRIEF

published on 05/28/2026 at 21:09, 1 month 13 days ago

OSE Immunotherapeutics Secures Flexible Bridge Equity Financing

Strategic Plan Clinical Development Institutional Investors Share Issuance Flexible Financing
PRESS RELEASE

published on 05/28/2026 at 21:04, 1 month 13 days ago

OSE Immunotherapeutics met en place un financement relais flexible en fonds propres
OSE Immunotherapeutics lance un financement relais flexible en fonds propres avec IRIS Capital Investment pour un montant pouvant atteindre 19,3 millions d'euros sur 24 mois, prolongeant ainsi son horizon de trésorerie jusqu'à fin décembre 2026

Financement Fonds Propres OSE Immunotherapeutics Horizon De Trésorerie IRIS Capital Investment
PRESS RELEASE

published on 05/28/2026 at 21:04, 1 month 13 days ago

OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
OSE Immunotherapeutics announces a flexible bridge equity financing with IRIS Capital Investment to raise €19.3 million, extending cash runway to December 2026 as part of a global financing strategy

OSE Immunotherapeutics Cash Runway Extension Bridge Equity Financing IRIS Capital Investment Global Financing Strategy
BRIEF

published on 05/22/2026 at 07:35, 1 month 19 days ago

OSE Immunotherapeutics Announces Positive Results in Ovarian Cancer Trial

Ovarian Cancer Clinical Trial Results OSE Immunotherapeutics Tedopi® TEDOVA Phase 2
BRIEF

published on 05/22/2026 at 07:35, 1 month 19 days ago

OSE Immunotherapeutics annonce des résultats positifs dans un essai clinique sur le cancer de l'ovaire

Résultats Des Essais Cliniques Tedopi® Immunothérapies OSE Cancer De L'ovaire Phase 2 De TEDOVA
PRESS RELEASE

published on 05/22/2026 at 07:30, 1 month 19 days ago

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer
OSE Immunotherapeutics announces positive topline results from TEDOVA Phase 2 trial with Tedopi® in recurrent ovarian cancer, presenting at ASCO 2026. Combination with pembrolizumab improves progression-free survival

OSE Immunotherapeutics Tedopi TEDOVA Phase 2 ASCO 2026 Recurrent Ovarian Cancer
BRIEF

published on 04/30/2026 at 07:35, 2 months 10 days ago

OSE Immunotherapeutics: 2025 Financial Review and 2026 Outlook

Strategic Partnerships OSE Immunotherapeutics 2025 Financial Results Tedopi® Cash Flow 2026

Published on 07/11/2026 at 00:00, 1 hour 41 minutes ago

Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/11/2026 at 00:00, 1 hour 41 minutes ago

LNG Energy Group Provides Operational Update
Published on 07/10/2026 at 23:00, 2 hours 41 minutes ago

Eskay Mining Corp. Updates Early Warning Disclosure Relating to Garibaldi Resources Corp.
Published on 07/10/2026 at 21:55, 3 hours 46 minutes ago

Golden Minerals Company Announces Results of Director Elections at 2026 Annual Meeting
Published on 07/10/2026 at 21:10, 4 hours 31 minutes ago

Linear Minerals Corp Announces Share Consolidation

View all ACCESSWIRE

Published on 07/10/2026 at 18:50, 6 hours 50 minutes ago

NNS acquires shares in OCI
Published on 07/10/2026 at 18:40, 7 hours ago

AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives
Published on 07/10/2026 at 17:45, 7 hours 55 minutes ago

WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026
Published on 07/10/2026 at 17:45, 7 hours 55 minutes ago

EUROPLASMA: Modalités de mise à disposition des documents préparatoires et de participation à l’assemblée générale ordinaire et extraordinaire du 30 juillet 2026
Published on 07/10/2026 at 17:14, 8 hours 26 minutes ago

Form 8.3 - SAFESTAY PLC: Opening Position Disclosure

View all EQS

Published on 07/10/2026 at 18:00, 7 hours 41 minutes ago

Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 18:00, 7 hours 41 minutes ago

Bilan semestriel du contrat de liquidité de la société CEGEDIM
Published on 07/10/2026 at 17:45, 7 hours 56 minutes ago

Half-year liquidity contract statement
Published on 07/10/2026 at 17:45, 7 hours 56 minutes ago

Bilan semestriel de mise en œuvre du contrat de liquidité
Published on 07/10/2026 at 17:45, 7 hours 56 minutes ago

HALF-YEAR LIQUIDITY CONTRACT STATEMENT

View all LES ECHOS COMFI WIRE

News